XML 86 R70.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
Research and development expenses | $ 781 | $ 1,474 | $ 2,803 | $ 1,990 | $ 649
General and administrative expenses | 2,494 | 3,339 | 6,509 | $ 3,778 | $ 1,902
Wages and related expenses [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
Research and development expenses | 202 | 243 | 436 |  |
General and administrative expenses | 217 | 245 | 437 |  |
Share-based payment [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
Research and development expenses | 23 | 224 | 264 |  |
General and administrative expenses | 45 | 431 | 633 |  |
Clinical studies [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
Research and development expenses | 145 | 106 | 369 |  |
Regulatory, professional and other expenses [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
Research and development expenses | 366 | 373 | 750 |  |
Research and preclinical studies [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
Research and development expenses | 45 | 410 | 703 |  |
Chemistry and formulations [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
Research and development expenses |  | 118 | 281 |  |
Professional and directors’ fees [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
General and administrative expenses | 1,366 | 1,292 | 2,499 |  |
Business development expenses [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
General and administrative expenses | 38 | 2 | 161 |  |
Office maintenance, rent and other expenses [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
General and administrative expenses | 48 | 63 | 224 |  |
Investor relations and business expenses [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
General and administrative expenses | 310 | 1,193 | 1,486 |  |
Wellution operating expenses [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
General and administrative expenses | 366 |  | 907 |  |
Regulatory expenses [Member] |  |  |  |  |
Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss [Line Items] |  |  |  |  |
General and administrative expenses | $ 104 | $ 113 | $ 162 |  |

X
- Definition The amount of expense relating to general and administrative activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_GeneralAndAdministrativeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 38 -IssueDate 2023-01-01 -Paragraph 126 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ResearchAndDevelopmentExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_AdditionalInformationtotheItemsofProfitorLossDetailsScheduleofAdditionalInformationtotheItemsofProfitorLossLineItems
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_WagesAndRelatedExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ShareBasedPaymentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ClinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ResearchAndPreclinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ChemistryAndFormulationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ProfessionalAndDirectorsFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_BusinessDevelopmentExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_OfficeMaintenanceRentAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_InvestorRelationsAndBusinessExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_WellutionOperatingExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |